Prudential Financial (ARQT) reports 5.30M-share stake; Jennison holds 4.98M
Rhea-AI Filing Summary
Prudential Financial, Inc. filed an Amendment No. 4 to a Schedule 13G/A reporting beneficial ownership of 5,302,713 shares of Arcutis Biotherapeutics Common Stock as of 03/31/2026, representing 4.3% of the class. The filing states Prudential is a Parent Holding Company and lists subsidiaries as indirect holders, including Jennison Associates LLC 4,980,770 and PGIM Quantitative Solutions LLC 256,545. The filing also discloses voting and dispositive power breakdowns: sole voting power 25,800, shared voting power 4,928,346, sole dispositive power 25,800, and shared dispositive power 5,276,913.
Positive
- None.
Negative
- None.
Insights
Prudential reports a minority stake of 4.3% in Arcutis as of 03/31/2026.
The filing quantifies total beneficial ownership at 5,302,713 shares and breaks down voting/dispositive powers. The majority of the position appears held indirectly through subsidiaries, notably Jennison Associates LLC 4,980,770.
Institutional holders and market participants may watch subsequent filings for any change in the reported percentage or in the composition of indirect holders.
Parent holding structure and voting power are clearly disclosed.
The Schedule 13G/A flags Prudential as a Parent Holding Company and lists subsidiaries with their respective share counts. The filing specifies both sole and shared voting and dispositive powers, which is important for understanding control influence.
Further amendments or Form 13D filings would be required to show activist intent; timing and intent are not stated here.
Key Figures
Key Terms
Schedule 13G/A regulatory
Parent Holding Company regulatory
Beneficially owned financial
AI-generated analysis. How Rhea-AI works. Not financial advice.